Graves
Arnaud R G G Potvin1, Ioana C Lacraru1, Peter H Bisschop2
1Orbital Center, Department of Ophthalmology, University Medical Center, University of Amsterdam, Amsterdam, Netherlands.
Graves' orbitopathy (GO) assessment needs better predictors beyond the clinical activity score (CAS). Combining clinical, imaging, and serological markers like TSI/TBII may improve treatment selection for Graves' disease patients.
さらに関連する動画
06:29Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
Published on: May 25, 2022
06:15Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
関連する概念動画
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Glaucoma: Overview
Nephrotic Syndrome II : Assessment and Medical Management
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
